Journal of Psychiatry Reform
  • About us
  • How to Contribute
  • FAQ
  • Contact us
ISSN 2371-4301
Search
  • Home
  • Editorials & Commentary
  • Papers
    • Review Articles
  • Abstracts
  • Educational Programs
  • Original Members
  • Contact us
ANTIDEPRESSANTS ARE COUNTERPRODUCTIVE IN BIPOLAR DISORDER
  • February 15, 2016,
  • 0Comments

ALAN EPPEL For decades, one of the most controversial issues within psychiatry has being whether or not antidepressants have any role to play in the treatment of bipolar disorder. Bipolar disorder consists of periods of depression and periods ..

  • Posted by Alan Eppel
  • Posted in Review Articles
The 2016 CANMAT Depression Guidelines: Redefining Levels of Evidence and Levels of Funding
  • May 20, 2017,
  • 0Comments

VOL 2 #7 Natasha Snelgrove MD, FRCPC   To much fanfare, and with an entire volume of the Canadian Journal of Psychiatry dedicated to these guidelines, the fourth iteration of the Canadian Network of Mood and Anxiety Treatment (CANMAT) Guideli..

  • Posted by Editor JPR
  • Posted in Editorials & Commentary
1. Bipolar Connectivity 2. Predicting Antidepressant Response
  • May 21, 2017,
  • 0Comments

VOL 2 #7     Resting state functional connectivity in women with bipolar disorder during clinical remission.   Syan SK(1,)(2), Minuzzi L(1,)(2,)(3,)(4), Smith M(4), Allega OR(1,)(2), Hall  GB(1,)(5), Frey BN(1,)(2,)(3,)(4). &nb..

  • Posted by Editor JPR
  • Posted in Abstracts
Agomelatine: is it really a firstline drug?
  • March 25, 2018,
  • 0Comments

  Vol 3 #2 March 2018   Agomelatine is listed as a firstline medication for the treament of depression in a number of guidelines including Canadian Guidelines. This is the case eventhough Agomelatine is not approved for use in Canada..

  • Posted by Editor JPR
  • Posted in Abstracts,Brief Review
Survey of Antidepressant First Choice
  • January 17, 2019,
  • 0Comments

The survey was sent to 105 psychiatrists working at an Academic Health Sciences Centre in Ontario Canada with multiple hospital sites.There were 41 responses which equals 39%. Survey Question Which antidepressant would you choose as your first..

  • Posted by Alan Eppel
  • Posted in Surveys
Network Meta-analysis of Antidepressants: A Bridge Too Far?
  • January 23, 2019,
  • 0Comments

Volume 5 # 1 January 2019   Alan Eppel MB, FRCPC McMaster University   ABSTRACT   Network Meta-analysis (NMA) is a powerful  statistical tool that expands the methods of  pairwise Meta-analysis. In this overview NMA is explain..

  • Posted by Alan Eppel
  • Posted in Articles,Editorials & Commentary,Uncategorized
Buspirone for SSRI induced Bruxism
  • April 20, 2021,
  • 0Comments

Vol 10 #6     Alan Eppel MB, FRCPC   Introduction Bruxism although originally identified as a mechanical dental problem has more recently been recognized as a form of abnormal muscle movements. Bruxism is described as a repetiti..

  • Posted by Alan Eppel
  • Posted in Brief Review,Clinical Pearls
A Caution Regarding Conclusions Based on Population-Based Analysis: Consider the Clinical Confounders
  • May 9, 2022,
  • 0Comments

Journal of Psychiatry Reform  Vol 11 # 7, May 2022   James A. Bourgeois, O.D., M.D.1,✉, Ana Hategan, M.D.2,iD Author information: 1  Clinical Professor, CL Psychiatrist, Chair, Department of Psychiatry, Baylor Scott & White H..

  • Posted by Editor JPR
  • Posted in Letters to the Editor
Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis
  • November 13, 2022,
  • 0Comments

BMJ Open 2019;9:e024886. doi: 10.1136/bmjopen-2018-024886 Reprinted in the Journal of Psychiatry Reform Vol 9 #16. November 14, 2022 under the Creative Commons CC-BY-NC 4.0 license Authors Klaus Munkholm,   Asger Sand Paludan-Müller, ..

  • Posted by Editor JPR
  • Posted in Articles,Creative Commons Republished,Editorials & Commentary
Antidepressant Trials Need Radical Methodology Reform
  • November 14, 2022,
  • 0Comments

Journal of Psychiatry Reform Vol 9 #17. November 15, 2022 Author Alan Eppel MB, MRCPsych, FRCPC The author has no conflicts of interest. In this edition of the journal we have reprinted a Danish Cochrane reanalysis of a meta-analysis conducted..

  • Posted by Editor JPR
  • Posted in Editorials & Commentary
  • 1
  • 2
Creative Commons License
This work is licensed under a Creative Commons Attribution Non-Commercial No-Derivatives 4.0 International License.